APP Gene Cerebral Amyloid Angiopathy APP Related Genetic Test sale cost 4400 AED
RYR1 Gene Central Core Disease Genetic Test sale cost 4400 AED RYR1 Gene Central Core Disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
LMNA Gene CMT2B1 Genetic Test sale cost 4400 AED LMNA Gene CMT2B1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

APP Gene Cerebral Amyloid Angiopathy APP Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “APP Gene Cerebral Amyloid Angiopathy APP Related Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the APP gene, which can lead to cerebral amyloid angiopathy (CAA). This condition is characterized by the accumulation of amyloid proteins in the walls of the cerebral arteries, leading to a range of neurological problems, including an increased risk of hemorrhagic stroke. The test is critical for individuals with a family history of CAA or related symptoms, as it can provide essential information for early diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of APP gene mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

APP Gene Cerebral amyloid angiopathy APP related Genetic Test

At DNA Labs UAE, we offer the APP Gene Cerebral amyloid angiopathy APP related Genetic Test. This test aims to identify mutations or variants in the APP gene that increase the risk of developing cerebral amyloid angiopathy.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

The APP Gene Cerebral amyloid angiopathy APP related Genetic Test utilizes NGS (Next-generation sequencing) technology for analysis.

Test Type

This test is specifically designed for Neurological Disorders.

Doctor

The test is recommended by Neurologists.

Test Department

The test is conducted in our Genetics department.

Pre Test Information

Prior to taking the APP Gene Cerebral amyloid angiopathy APP related Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected with APP Gene Cerebral amyloid angiopathy.

Test Details

The APP gene is associated with cerebral amyloid angiopathy, a condition characterized by the buildup of amyloid proteins in the brain’s blood vessel walls. This can lead to hemorrhages and cognitive decline. The NGS genetic testing for APP gene helps in identifying mutations or variants that increase the risk of developing cerebral amyloid angiopathy. This information is crucial for early diagnosis and management of the condition.

NGS (Next-generation sequencing) is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes. This makes it a valuable tool in genetic testing for inherited disorders.

Test Name APP Gene Cerebral amyloid angiopathy APP related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for APP Gene Cerebral amyloid angiopathy, APP related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with APP Gene Cerebral amyloid angiopathy, APP related
Test Details

APP gene is associated with cerebral amyloid angiopathy, which is a condition where amyloid proteins build up in the walls of blood vessels in the brain, leading to hemorrhages and cognitive decline.

NGS genetic testing for APP gene can help identify mutations or variants that increase the risk of developing cerebral amyloid angiopathy. This information can be useful in early diagnosis and management of the condition.

NGS (Next-generation sequencing) is a high-throughput DNA sequencing technology that can analyze multiple genes simultaneously, making it a valuable tool in genetic testing for inherited disorders.

SKU: TEST-1153 Category:

Related products